Product image of Enwylma (Denosumab) supplied by GNH India

Enwylma

Active Ingredient:
Denosumab
Origin:
EU

Enwylma (Denosumab)

Enwylma (Denosumab) is a subcutaneous injection used to manage bone-related conditions. Learn about its uses, effects, and precautions for informed healthcare decisions.

Manufacturer / TM Owner

Zentiva, K.S.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Enwylma (Denosumab) is primarily used to treat conditions related to bone health, such as osteoporosis and bone metastases. It works by inhibiting a protein that affects bone breakdown, helping to maintain bone density and reduce the risk of fractures. This medication is often prescribed for individuals with a high risk of bone-related complications.

Side Effects

  • Common effects of Enwylma (Denosumab) may include mild reactions at the injection site, such as redness, swelling, or itching. Some users might experience muscle pain, headache, or fatigue. These effects are generally mild and temporary, but any persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

  • Enwylma (Denosumab) should be used with caution in individuals with a history of low calcium levels or dental issues. Regular monitoring of calcium levels is recommended. It is important to follow the prescribed dosage and administration instructions to minimize potential risks.

Avoid Interactions

  • Enwylma (Denosumab) may interact with certain medications, including those that affect the immune system or bone metabolism. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.

Frequently Asked Questions

Enwylma (Denosumab) is used to manage bone-related conditions, such as osteoporosis and bone metastases, by inhibiting bone breakdown.

Enwylma (Denosumab) is administered via subcutaneous injection, typically by a healthcare professional.

Common side effects may include mild reactions at the injection site, muscle pain, headache, or fatigue.

Enwylma (Denosumab) may interact with certain medications, so it is important to consult a healthcare provider before combining it with other treatments.

Enwylma (Denosumab) should be stored according to the manufacturer's instructions, typically at room temperature and protected from light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Denosumab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT